Navigation Links
Rocky Mountain Biologicals Expands Custom Serum Filtration Facility

Missoula, Montana (PRWEB) April 08, 2013

To help supply the growing global demand for ultra-high quality serum and protein fractionation manufacturing, Rocky Mountain Biologicals’ protein fractionation manufacturing and serum filtration facility in Missoula, Montana has been expanded to 20,000 square feet.

With the new addition RMBIO gains an additional 6,000 liters of production and custom serum filtration capacity. This addition doubles RMBIO's capabilities for serum filtration. The increased capacity allows for large lot sizes, minimizes lot to lot variability, and helps RMBIO continue to provide ultra-high quality products that provide extremely consistent cell growth in cell culture applications.

Expanded freezer capacity allows RMBIO to further enhance its global supply chain optimization initiative. Continuing to source bovine raw materials from the safest sources, including Australia, New Zealand and the U.S., is helping to make RMBIO one of the most trusted suppliers of specialized blood products in the world. RMBIO's product descriptions are listed on their web site at , and include Bovine, Horse, Porcine and other serum and biologicals used worldwide by medical and pharmaceutical companies.

According to RMBIO's CEO Suresh Daniel, the expansion has been done in timely way. Daniel stated, “We are experiencing ever-increasing demand for our serum products, particularly fetal bovine serum and new born calf serum. The worldwide supply of these serum products is tight right now as a result of the cyclical nature of the cattle industry. Thus the demand for our bovine cholesterol products, which reduce or eliminate the need for fetal bovine serum in cell culture applications, is also at an all-time high.”

Production capacity of Rocky Mountain Biologicals cell culture grade lipoprotein cholesterol concentrate product, Lipogro, as well as RMBIO's custom LDL cholesterol fraction product has been enhanced by the expansion. RMBIO also produces a porcine cholesterol concentrate, which is high in LDL, for use in the diagnostic industry.

About Rocky Mountain Biologicals: RMBIO ( ) is a global manufacturer of high quality, specialized biological products, including lipoprotein and cholesterol solutions, bovine serum albumin (BSA), sera, and water for injection products. RMBIO's products are manufactured and tested according to GMP requirements. These products are sourced from domestic (U.S.) and Australian/New Zealand raw material for use as cell culture growth factors and diagnostic test materials. These products are used by many of the world’s largest pharmaceutical, biotechnology, diagnostic, animal health and research institutions.

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Tote Mixers In 48 Hours From White Mountain Process Mixers, Agitators & Blenders
2. White Mountain Process Introduces Squeal-less Mechanical Seal
3. Tissue Culture Biologicals, Inc. Hires James D. Titus to Lead New Expansion and Branding Development Effort
4. Novus Biologicals Hires David Eansor to Lead New Corporate-Development Effort
5. PhoenixSongs Biologicals, Inc. Announces Enhanced Neural Lineage-specific Cell Culture Media Products Release
6. GenoSpace Expands Its Management Team by Appointing Daniel Meyer as Chief Financial Officer
7. GLM Displays Expands Its Line of Formulate Fabric Displays with the Vibe 10ft Display
8. Shire to Acquire SARcode Bioscience, Expands Presence in Ophthalmology
9. Leading Chemical Manufacturer Expands Biobased Offering through Unique Distribution of Proven Green Spill Absorbent
10. Defying Industry Trends, BBK Worldwide Expands Ownership From Within
11. Abacus International Expands Annual Partnership With HealthEconomics.Com
Post Your Comments:
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... STACS DNA ... Technical Leader at the Arkansas State Crime Laboratory, has joined STACS DNA as a ... STACS DNA team,” said Jocelyn Tremblay, President and COO of STACS DNA. “In further ...
(Date:6/23/2016)... , June 23, 2016 Apellis ... Phase 1 clinical trials of its complement C3 ... single and multiple ascending dose studies designed to ... (PD) of subcutaneous injection in healthy adult volunteers. ... (SC) either as a single dose (ranging from ...
(Date:6/23/2016)... , June 23, 2016 ... Hematology Review, 2016;12(1):22-8 ... , the peer-reviewed journal from touchONCOLOGY, Andrew ... escalating cost of cancer care is placing an ... result of expensive biologic therapies. With the patents ...
(Date:6/23/2016)... ... June 23, 2016 , ... ClinCapture, the only free ... and will showcase its product’s latest features from June 26 to June 30, ... poster on Disrupting Clinical Trials in The Cloud during the conference. DIA ...
Breaking Biology Technology:
(Date:6/7/2016)... 7, 2016  Syngrafii Inc. and San Antonio ... that includes integrating Syngrafii,s patented LongPen™ eSignature "Wet" ... collaboration will result in greater convenience for SACU ... while maintaining existing document workflow and compliance requirements. ... Highlights: ...
(Date:6/2/2016)...   The Weather Company , an IBM Business (NYSE: ... capability in which consumers will be able to interact with ... via voice or text and receive relevant information about the ... Marketers have long sought an advertising solution that can create ... relevant and valuable; and can scale across millions of interactions ...
(Date:5/24/2016)... May 24, 2016 Ampronix facilitates superior patient care by providing unparalleled technology ... LCD display is the latest premium product recently added to the range of products ... ... ... 3d Imaging- LCD Medical Display- Ampronix News ...
Breaking Biology News(10 mins):